Novartis Secures Positive EU Backing for SMA Gene Therapy Itvisma [Yahoo! Finance]
Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA) [Yahoo! Finance]
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants [Yahoo! Finance]
Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants
Novartis: Buy Thesis Fades Into Q1 2026 Results (Rating Downgrade) [Seeking Alpha]